Related Experiment Videos
Translocation (19;?) in two stage II neuroblastomas
Cancer Genetics and Cytogenetics
|February 1, 1986
Summary
Chromosomal analysis of two pediatric neuroblastomas revealed a consistent translocation on chromosome 19. Both patients are tumor-free after surgical treatment, indicating potential prognostic significance.
Area of Science:
- Pediatric Oncology
- Cytogenetics
- Cancer Genomics
Background:
- Neuroblastoma is a common pediatric cancer originating from immature nerve cells.
- Understanding chromosomal abnormalities is crucial for diagnosis and prognosis in neuroblastoma.
- This study investigates the chromosomal makeup of two Stage II neuroblastoma cases.
Observation:
- Two abdominal neuroblastomas (Stage II) from a 10-month-old male and a 6-year-old female were analyzed.
- Modal chromosome numbers were 70 and 46, respectively.
- No double minute chromosomes (DM) or homogeneously staining regions (HSR) were observed.
Findings:
- A consistent aberration identified was a translocation on the short arm of chromosome 19 in both tumors.
- No visible structural abnormalities of chromosome 1 were detected.
- The specific translocation involving chromosome 19 appears to be a shared characteristic.
Implications:
- The identified chromosome 19 translocation may serve as a potential biomarker in pediatric neuroblastoma.
- Further research is warranted to explore the prognostic and therapeutic implications of this chromosomal abnormality.
- The successful resection and current disease-free status of both patients highlight the importance of timely surgical intervention.